KATIE Price has revealed that her son Harvey has lost five stone without taking any fat jabs. The mum-of-five, 47, took to ...

Priory has officially opened its first non-medical, residential addiction therapy service, marking a major step in making ...

Manhattan-based psychotherapist Jonathan Alpert told Fox News on Friday that "Trump Derangement Syndrome" (TDS) is a real psychological issue he has seen firsthand in his practice, with three-quarters ...

Is “Trump derangement syndrome” real? No serious mental-health professional would render such a partisan and derogatory diagnosis. Yet I’ve seen it in my own psychotherapy practice. Patients across ...

Detailed price information for Bright Minds Biosciences Inc (DRUG-Q) from The Globe and Mail including charting and trades.

Every time Gee and I criticize President Trump or his administration, some listeners text in with that tired refrain: “You’ve got Trump Derangement Syndrome.” It used to bug me. Now? I wear it like a ...

Prader-Willi syndrome is a rare genetic condition that leads to physical and behavioral problems. A common feature of the condition is feeling hungry all the time, and people with Prader-Willi have an ...

Eldest daughter syndrome isn't in the DSM-5, but that doesn't make the experiences of eldest daughters any less real. Eldest daughter syndrome can look like intense perfectionism, unrealistic high ...

Soleno Therapeutics is breathing easier with a report from Acadia Pharmaceuticals that its candidate to treat hyperphagia in patients with Prader-Willi Syndrome (PWS) has come up short in a phase 3 ...

SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin ...

Treatment with intranasal carbetocin was not associated with a statistically significant improvement in hyperphagia compared with placebo. Topline results were announced from a phase 3 trial ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...